Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway

Tsai‐Kun Wu(Mackay Junior College of Medicine, Nursing and Management), CHIA-JEN LEE(Tungs' Taichung MetroHarbor Hospital)
Anticancer Research
July 19, 2021
Cited by 4


Related Papers